ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

VAD

November 15, 2014
Selzman and colleagues provide an outstanding overview of the state of the art of bridge to recovery, describing a paradigm shift that has been occurring.  A consistent theme over the years is that recovery likelihood is enhanced in younger patients, those with non-ischemic cardiomyopathy, and those who have had HF for shorter durations.
November 13, 2014
The authors describe an alternative technique for insertion of a temporary RVAD so as to allow minimally invasive removal  without sternotomy after RV recovery.  An elongated graft is sewn to the PA and exited in the subxyphoid area at a site that is separate from the sternotomy incision.  After exiting, the graft is attached to an outflow cannula.
November 10, 2014
The effects of exercise, increasing pump speed, or both on invasive hemodynamics in centrifugal flow LVAD patients were analyzed in this small study.  Findings included:
November 3, 2014
Left ventricular assist devices (LVADs) are increasingly used for the treatment of end-stage congestive heart failure, both as a bridge to transplantation and as destination therapy (1).
October 22, 2014
This survey of publicly available information on LVAD for patients considering such therapy identified numerous flaws in the materials.  All discussed benefits, few discussed surgical issues, quality of life, and complications.  Some had outdated statistics, some were written above a 3rd grade level, and most did not meet international standards.  Th
September 4, 2014
The impact of continuous flow VAD on survival among patients awaiting heart transplant is not well known.  Pts on the UNOS list were propensity score matched 1:2 (HeartMate II vs no VAD). Wait list mortality was 10% during the 7.5 year study.  Use of a VAD improved survival to transplant at 1 (91% vs 77%) and 2 years (85% vs 68%).  Use of VAD as a br
May 21, 2014
The influence of continuous flow LVAD devices on heart transplant was examined using UNOS data, comparing outcomes of cfLVAD to pulsatile flow LVAD (pfLVAD) and no LVAD pts.   cfLVAD pts spent longer time on the waitlist and were status IA for longer than either of the other groups.  Waitlist survival was better for the cfLVAD pts.  Post-transplant s

Pages